More Information
Summary:THE INVENTION RELATES TO THE ALLERGENIC LATEX PROTEIN HEV B 4. THE FULL cDNA SEQUENCE OF THE SMALLER PROTEIN COMPONENTS OF HEV B 4 IS DISCLOSED, TOGETHER WITH THE AMINO ACID SEQUENCE OF THOSE COMPONENTS AND THE SYNTHESIS OF A RECOMBINANT PROTEIN USING THE AFORESAID DNA SEQUENCE OR A SYNTHETIC PEPTIDE DERIVED FROM THE AMINO ACID SEQUENCE. THE USE OF THE HEV B 4 PROTEIN COMPLEX AND OF AN ANTIBODY AGAINTS THAT PROTEIN IS DESCRIBED IN IMMUNOASSAYS AND IN IMMUNOTHERAPY FOR THE RELIEF OF ALLERGY OR ALLERGY SYMPTOMS.
Bibliography:Application Number: MY2004PI00947